Israel Englander Cure Vac N.V. Transaction History
Millennium Management LLC
- $175 Billion
- Q1 2025
A detailed history of Israel Englander (Millennium Management LLC) transactions in Cure Vac N.V. stock. As of the latest transaction made, Millennium Management LLC holds 1,816,984 shares of CVAC stock, worth $9.99 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,816,984
Previous 1,647,037
10.32%
Holding current value
$9.99 Million
Previous $5.62 Million
10.38%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding CVAC
# of Institutions
95Shares Held
10.7MCall Options Held
75.1KPut Options Held
86.7K-
Black Rock Inc. New York, NY2.25MShares$12.4 Million0.0% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$8.63 Million10.6% of portfolio
-
Ubs Group Ag843KShares$4.64 Million0.0% of portfolio
-
Gsa Capital Partners LLP London, X0308KShares$1.69 Million0.08% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL280KShares$1.54 Million0.0% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $1.03B
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...